4CPS-126 Analysis of the effectiveness of pertuzumab as neoadyuvant treatment in patients with her2-positive breast cancer

Autor: Riquelme, N de Béjar, Arcos, JC Titos, Luengas, A Agéámez, Leéáñero, V Dominguez, Manuel, SS, Saura, MA Meroéáñño, Alberto, GG, Zamora, C Fernandez, Diaz, B Arribas, Dominguez, MT Alonso, Villar, J Leon

Publikováno v: European Journal of Hospital Pharmacy : Science and Practice; 2018, Vol. 25 Issue: Supplement 1 pA100-A101, 2p